getting paid seems to be an issue for them. When investors look at the medical space generally, this isn’t something they see as a risk. So this is a big negative associated with the countries they operate in.
discounted rights issue coming to force existing holders to dip into their wallets. I agree with Wilbur’s comments above, no point selling even if you could get out
Ann: 2022 Q4 Quarterly Activities Report and Appendix 4C, page-5
Add IME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.85M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 2442 | 2 |
View Market Depth
| Last trade - 16.12pm 19/07/2024 (20 minute delay) ? |
| IME (ASX) Chart |
Day chart unavailable